Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-28 9:52 pm Purchase | 2025-03-26 | 13D | Elevai Labs, Inc. Common Stock ELAB | Graydon Bensler | 3,036,437 47.640% | 3,036,437 (New Position) | Filing History |
| 2025-03-28 9:47 pm Purchase | 2025-03-26 | 13D | Elevai Labs, Inc. Common Stock ELAB | Braeden Lichti | 3,336,437 52.350% | 3,336,437 (New Position) | Filing History |
| 2025-03-28 9:46 pm Purchase | 2024-09-24 | 13D | Elevai Labs, Inc. Common Stock ELAB | Braeden Lichti | 2,733 0.190% | 2,733 (New Position) | Filing History |
| 2025-03-24 4:27 pm Purchase | 2025-03-21 | 13G | Elevai Labs, Inc. Common Stock ELAB | BIGGER CAPITAL FUND L P | 68,689 9.710% | 68,689 (New Position) | Filing History |
| 2025-02-14 7:10 pm Purchase | 2024-12-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Anson Funds Management LP | 151,501 4.900% | 149,900 (+9364.25%) | Filing History |
| 2025-02-14 11:14 am Purchase | 2024-12-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Altium Capital Management LLC | 27,697 3.900% | 27,697 (New Position) | Filing History |
| 2025-01-31 4:19 pm Purchase | 2025-01-27 | 13G | Elevai Labs, Inc. Common Stock ELAB | S.H.N. Financial Investments Ltd. | 55,393 9.600% | 53,221 (+2449.69%) | Filing History |
| 2024-11-14 5:53 pm Purchase | 2024-09-30 | 13G | Elevai Labs, Inc. Common Stock ELAB | Anson Funds Management LP | 1,601 9.900% | 1,601 (New Position) | Filing History |
| 2024-10-02 4:01 pm Purchase | 2024-09-24 | 13G | Elevai Labs, Inc. Common Stock ELAB | S.H.N. Financial Investments Ltd. | 2,173 9.990% | 2,173 (New Position) | Filing History |
| 2024-10-01 4:01 pm Purchase | 2024-09-24 | 13G | Elevai Labs, Inc. Common Stock ELAB | L1 Capital Global Opportunities Master Fund, Ltd. | 2,265 9.990% | 2,265 (New Position) | Filing History |
| 2024-09-26 6:28 pm Purchase | 2024-09-23 | 13G | Elevai Labs, Inc. Common Stock ELAB | Altium Capital Management LLC | 4,082 9.990% | 4,082 (New Position) | Filing History |
| 2024-08-16 10:01 am Purchase | 2024-08-15 | 13G | Elevai Labs, Inc. Common Stock ELAB | Santorio Biomedical, LLC | 875 5.900% | 875 (New Position) | Filing History |
| 2024-05-31 8:10 pm Purchase | 2024-05-07 | 13G | Elevai Labs, Inc. Common Stock ELAB | MOA LIFE PLUS CO. LTD. | 679 5.030% | 679 (New Position) | Filing History |
| 2024-02-21 10:57 am Purchase | 2023-11-13 | 13D | Elevai Labs, Inc. Common Stock ELAB | Braeden Lichti | 2,731 22.070% | 2,731 (New Position) | Filing History |
| 2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Abou-Sayed Hatem | 1,084 8.700% | 1,084 (New Position) | Filing History |
| 2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Hatem Abou-Sayed MD MBA FACS a Professional Medical Corp | 980 7.900% | 980 (New Position) | Filing History |
| 2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | Plews Jordan R. | 2,141 17.000% | 2,141 (New Position) | Filing History |
| 2024-02-14 09:30 am Purchase | 2023-01-31 | 13G | Elevai Labs, Inc. Common Stock ELAB | JP Bio Consulting LLC | 2,037 16.500% | 2,037 (New Position) | Filing History |